http://www.editasmedicine.com
Editas Medicine, Inc. Company Intro
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Industry
Healthcare
Editas Medicine, Inc. Headquaters
11 Hurley Street
Cambridge,02141
United States
Editas Medicine, Inc. Share price
22 Jan 2021 01:32 GMT
$67.91
-3.85 (-5.37 %)
Editas Medicine, Inc. Market cap
$4.018 B
WMC RANKING
2021
Editas Medicine, Inc. # 156
BiotechnologyLatest Editas Medicine, Inc. News
22 Jan 2021
Editas Medicine, Inc. (EDIT) Volatility Reaches 8.81% : Sit Tight
Editas Medicine, Inc. (NASDAQ:EDIT) concluded the trading at $63.79 on Thursday, Jan 21, with a fall of -11.11% from its closing price on previous day.
22 Jan 2021
Now Is A Good Time To Buy Editas Medicine, Inc. (NASDAQ:EDIT)
During the recent session, Editas Medicine, Inc. (NASDAQ:EDIT)'s traded shares were 1,328,689, with the beta value of the company hitting 2.09. At the end of ...
22 Jan 2021
Editas Medicine Inc. [EDIT] fell -9.01% so far this year. What ...
Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, announced the pricing of an underwritten offering of 3,500,000 shares of its common stock ...
WMC Market Score
WMC Market to Revenue Score
Editas Medicine, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Editas Medicine, Inc. | USD | $14,366 | $142,119 | $-121,031 | $40,180B | 156 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Editas Medicine, Inc. Social Followers vs Top 4 Industry Competitors
Editas Medicine, Inc. Post vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Editas Medicine, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Editas Medicine, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Editas Medicine, Inc. | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
